They have been reported to target several extracellular matrix-related genes [54], in particular collagens [53, 55, 56], and their silencing [55] or their downregulation by TGF-β [56, 57] is thought to promote fibrosis or systemic sclerosis [56]. Here, TGFB1 is linked to systemic sclerosis.